Low-density lipoprotein cholesterol and survival in pulmonary arterial hypertension.

Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet (2007) 15.27

IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial. Ann Rheum Dis (2008) 6.97

Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition. JAMA (2004) 4.54

Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension. Circulation (2010) 3.02

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J (2015) 2.48

2. Classification and Diagnosis of Diabetes. Diabetes Care (2016) 2.26

Effects of antirheumatic therapy on serum lipid levels in patients with rheumatoid arthritis: a prospective study. Am J Med (2002) 2.13

The relationship between cholesterol and survival in patients with chronic heart failure. J Am Coll Cardiol (2003) 2.12

Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions. Ann Rheum Dis (2009) 2.03

Potential pathogenic role of soluble receptor activator of nuclear factor-ĸB ligand and osteoprotegerin in patients with pulmonary arterial hypertension. Pol Arch Med Wewn (2014) 2.03

Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice. J Clin Invest (1990) 2.02

C-reactive protein in heart failure: prognostic value and the effect of valsartan. Circulation (2005) 1.92

Macropinocytosis is the endocytic pathway that mediates macrophage foam cell formation with native low density lipoprotein. J Biol Chem (2004) 1.92

Plasma levels of high-density lipoprotein cholesterol and outcomes in pulmonary arterial hypertension. Am J Respir Crit Care Med (2010) 1.85

Insulin resistance in pulmonary arterial hypertension. Eur Respir J (2008) 1.80

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR). Atherosclerosis (2016) 1.78

Comprehensive analysis of inflammatory markers in chronic thromboembolic pulmonary hypertension patients. Eur Respir J (2014) 1.50

Effect of Statin Treatment and Low-Density Lipoprotein-Cholesterol on Short-Term Mortality in Acute Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention　- Multicenter Registry From Tokyo CCU Network Database. Circ J (2015) 1.48

Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension. Circ Res (2014) 1.38

C-reactive protein: a new predictor of adverse outcome in pulmonary arterial hypertension. J Am Coll Cardiol (2009) 1.34

High-density vs low-density lipoprotein cholesterol as the risk factor for coronary artery disease and stroke in old age. Arch Intern Med (2003) 1.24

Dyslipidemia and rheumatoid arthritis. Ann Rheum Dis (1997) 1.06

Interactions of the heart and the liver. Eur Heart J (2013) 1.04

LDL and HDL subclasses in acute ischemic stroke: prediction of risk and short-term mortality. Atherosclerosis (2009) 0.99

Changes in serum lipids and lipoproteins in cancer patients during chemotherapy. Cancer Chemother Pharmacol (1992) 0.95

Lipoprotein(a) and lipids in relation to inflammation in rheumatoid arthritis. Clin Rheumatol (2000) 0.93

Reverse epidemiology of lipid-death associations in a cohort of end-stage renal disease patients. Nephron Clin Pract (2011) 0.88

Receptor-independent catabolism of low density lipoprotein. Involvement of the reticuloendothelial system. J Biol Chem (1982) 0.88

Dyslipidemia, malnutrition, inflammation, cardiovascular disease and mortality in chronic kidney disease. Curr Opin Lipidol (2014) 0.87

Prevalence and control of cardiovascular risk factors in Poland. Assumptions and objectives of the NATPOL 2011 Survey. Kardiol Pol (2013) 0.87

Baseline low-density lipoprotein cholesterol levels and outcome in patients with heart failure. Am J Cardiol (2010) 0.85

Pulmonary artery pulse wave velocity in idiopathic pulmonary arterial hypertension. Can J Cardiol (2012) 0.82

Cholesterol--a marker of nutritional status in mild to moderate heart failure. Int J Cardiol (2007) 0.81

A Western-type diet attenuates pulmonary hypertension with heart failure and cardiac cachexia in rats. J Nutr (2011) 0.80

Serum high-density lipoprotein cholesterol levels as a prognostic indicator in patients with idiopathic pulmonary arterial hypertension. Am J Cardiol (2012) 0.80

Reduced pulmonary artery vasoconstriction in methacholine in cholesterol-fed rabbits. Hypertension (1996) 0.80

Integrating diet and inflammation to calculate cardiovascular risk. Atherosclerosis (2016) 0.80

Efficacy of Statin Therapy in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis. Sci Rep (2016) 0.80

Impact of insulin resistance on ventricular function in pulmonary arterial hypertension. J Heart Lung Transplant (2014) 0.79

Prognostic implications of serial risk score assessments in patients with pulmonary arterial hypertension: a Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) analysis. J Heart Lung Transplant (2014) 0.78

Polish forum for prevention guidelines on dyslipidaemia. Kardiol Pol (2008) 0.78

Long-Term Survival and Apolipoprotein A1 Level in Chronic Heart Failure: Interaction With Tumor Necrosis Factor α -308 G/A Polymorphism. J Card Fail (2016) 0.77

Polish Forum for Prevention Guidelines on overweight and obesity. Kardiol Pol (2008) 0.77

Atherosclerosis progression affects the relationship between endothelial function and aortic stiffness. Atherosclerosis (2008) 0.77

Low-Density Lipoprotein Cholesterol Level and Statin Therapy in Patients With Acute Myocardial Infarction (Cholesterol Paradox). Circ J (2015) 0.76

Relationships between nutritional status and markers of congestion in patients with pulmonary arterial hypertension. Int J Cardiol (2015) 0.76

Clinical significance of measuring inflammatory markers in patients with pulmonary arterial hypertension. Pol Arch Med Wewn (2015) 0.76

Validation of the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) pulmonary hypertension prediction model in a unique population and utility in the prediction of long-term survival. J Heart Lung Transplant (2012) 0.76

Substance use and mental diagnoses among adults with and without type 2 diabetes: Results from electronic health records data. Drug Alcohol Depend (2015) 0.81